Iovance Biotherapeutics (IOVA) FCF Margin (2023 - 2026)
Iovance Biotherapeutics' FCF Margin came in at -66.71% for Q2 2026, up 58.23 percentage points from -124.95% a year earlier and up 43.47 percentage points from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) FCF Margin (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Iovance Biotherapeutics reported FCF Margin of -91.21%, up 42.75 percentage points year-over-year; for FY2025, it was -127.61%, up 94.28 percentage points from FY2024.
- Going back by year, FCF Margin was -221.88% in FY2024 (+32083.41 pp) and -32305.30% in FY2023.
- The Q2 2026 figure represents the highest quarterly FCF Margin in data going back to Q2 2023.
- Year-over-year, FCF Margin has increased for three consecutive quarters, with an average year-over-year change of +6808.29 percentage points over the last eight quarters.
- The fastest year-over-year change in FCF Margin over five years came in Q2 2024 (a gain of 43157.78 percentage points), and the weakest in Q3 2025 (a drop of 28.13 percentage points).
- Business Quant data shows IOVA's FCF Margin at -110.19% (Q1 2026), -71.32% (Q4 2025) and -132.75% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.01% |
| 10 | Iovance Biotherapeutics | 6.61 Bn | 5.40 Bn | 55.72 Mn | -66.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -66.71% |
| Mar 31, 2026 | -110.19% |
| Dec 31, 2025 | -71.32% |
| Sep 30, 2025 | -132.75% |
| Jun 30, 2025 | -124.95% |
| Mar 31, 2025 | -222.82% |
| Dec 31, 2024 | -105.12% |
| Sep 30, 2024 | -104.62% |
| Jun 30, 2024 | -317.85% |
| Mar 31, 2024 | -17,685.31% |
| Dec 31, 2023 | -18,153.32% |
| Sep 30, 2023 | -18,690.83% |
| Jun 30, 2023 | -43,475.63% |
API Access
Iovance Biotherapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();